Atlas market file · Etf · United States
Direxion Daily S&P 500 High Beta Bull 3X ETFHIBL
- Last close
- 108.17
- Change
- +5.02%
- 96-bar range
- 51.92 – 138.11
- As of
- 7 Aug 2026
Direxion Daily S&P 500 High Beta Bull 3X ETF is an exchange-traded fund listed as HIBL on AMEX. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
- Identity
- Nasdaq Trader
- Chart rail
- TradingView
- File state
- Public profile
Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.
▮ up candle ▮ down candle
Weekly outlook: the last 104 weekly closes (+153.92% over the window).
Source rail: Yahoo Finance chart API (HIBL). This dated snapshot is the crawlable Atlas reference.
Live market viewTradingView · provider feed Open view ->
Open the attributed TradingView market view for HIBL. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.
HIBL public profile
Exchange-traded fund. Direxion Daily S&P 500 High Beta Bull 3X ETF is connected to current market context, cited company sources and its retained research file.
Direxion Daily S&P 500 High Beta Bull 3X ETF trades as HIBL on AMEX. Direxion Daily S&P 500 High Beta Bull 3X ETF (HIBL) has a latest verified close of 108.17, up 5.02%, dated 7 Aug 2026.
Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. HIBL stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.
What changed for Direxion Daily S&P 500 High Beta Bull 3X ETF today
HIBL is a concentrated ETF listed on Nasdaq that seeks 3x the daily return of the S&P 500 High Beta Index. The fund’s mandate is straightforward: take the index’s beta and apply a three-times multiplier each trading day, then reset at the close so yesterday’s losses don’t become tomorrow’s starting line. The catch is the 0.95% annual expense ratio, which is less ‘fee’ and more ‘annual vigilante’ that withdraws from the NAV regardless of whether the 3x worked for anyone. The issuer calls it a bullish amplifier; the math calls it a daily reset with compounding friction.
The fund’s top holdings are not single stocks but the S&P 500 High Beta Index itself, a basket designed to tilt toward the most volatile constituents of the S&P 500. At issuance, the index is concentrated in sectors where volatility is a feature, not a bug: technology, consumer discretionary, and real estate. Concentration risk is baked in because the mandate is beta, not diversification. The issuer’s marketing slides highlight ‘sector leadership’ while the prospectus quietly reminds readers that ‘high beta’ is often code for ‘high drawdown.’
The SEC filing confirms HIBL’s expense ratio at 0.95% and its daily reset mechanism; it does not confirm the fund’s long-term tracking versus the index’s 3x daily target because the reset resets every day. The fund’s AUM and liquidity data are not parsed in the SEC filing or Nasdaq listing page, so the public cannot verify daily volume or total assets under management from the supplied sources. What is clear is that the issuer’s marketing claims are subject to the daily reset and the 0.95% fee, both of which are documented but not explained in plain terms on the marketing page.
HIBL’s chart route is available on Nasdaq; the renderer will display the instrument’s price action without levels or commentary. Trading happens on Nasdaq during regular market hours, and the fund’s liquidity is a function of the market-maker’s willingness to quote inside the spread rather than any disclosed AUM figure. The fund is not required to disclose intraday holdings beyond the index description in the prospectus, so the only real-time transparency is the ticker tape and the prospectus footnotes.
The Nasdaq listing page shows the fund’s ticker and basic market data but does not parse the index constituents, turnover, or the index’s own expense ratio, which sits beneath HIBL’s headline fee. The SEC filing confirms the expense ratio and the 3x daily reset but does not supply the index’s methodology file, so the investor must trust that the ‘High Beta’ label does what it says on the tin. The fund’s tracking difference versus the index’s 3x daily return is not disclosed in the supplied sources, leaving the performance gap between marketing and math unquantified.
The fund’s current data points-ticker, expense ratio, reset rule, and Nasdaq listing-are sourced, but the basket’s live composition, the index’s live beta calculation, and the fund’s live AUM are not parsed in the evidence. The document trail stops at the SEC filing and the Nasdaq market activity page; everything beyond that is either in the prospectus (not parsed here) or in the index provider’s black box (not supplied).
Sources & evidence · 3 links
This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.
HIBL technical readout
Directional bias down. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-28. Indicators are descriptive statistics, not investment advice.
Open an Atlas research path on HIBL
FreedomCore Atlas can expand this public profile into source-led research files with holdings and concentration, index methodology, exposure and overlap, fees and tracking difference, and liquidity context. Each path keeps the underlying public sources visible.
Open Atlas workstation ->Keep HIBL research in your Atlas archive
Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.
Checking Atlas access...
HIBL FAQ
What is Direxion Daily S&P 500 High Beta Bull 3X ETF (HIBL)?Direxion Daily S&P 500 High Beta Bull 3X ETF (HIBL) has a latest verified close of 108.17, up 5.02%, dated 7 Aug 2026. Use this page to check the price chart, company...
Direxion Daily S&P 500 High Beta Bull 3X ETF (HIBL) has a latest verified close of 108.17, up 5.02%, dated 7 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
What does Atlas show for HIBL?Direxion Daily S&P 500 High Beta Bull 3X ETF (HIBL) has a latest verified close of 108.17, up 5.02%, dated 7 Aug 2026. It brings the latest available chart, company...
Direxion Daily S&P 500 High Beta Bull 3X ETF (HIBL) has a latest verified close of 108.17, up 5.02%, dated 7 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. HIBL stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.
How often is the HIBL page updated?The HIBL public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...
The HIBL public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.
Which sources does Atlas use for HIBL?The HIBL file starts with Nasdaq Trader and TradingView AMEX:HIBL. The page separates verified market context from company evidence and shows open evidence gaps instead...
The HIBL file starts with Nasdaq Trader and TradingView AMEX:HIBL. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.
Can Atlas run a full research brief on HIBL?Yes. The workstation can open HIBL, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Yes. The workstation can open HIBL, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Is this HIBL page investment advice?No. The HIBL page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...
No. The HIBL page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.
Methodology
This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.
Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.
Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes →
HIBL
Etf · evidence first